Montag & Associates’s Itron ITRI Stock Holding History

Montag & Associates’s Portfolio ITRI Stock Details ITRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7	Closed	-$872	–	1060
2025 Q3	$872	Buy	+7	New	+$890	﹤0.01%	1032

Other funds holding ITRI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Montag & Associates's ITRI Position: Q4 2025 in Review

Montag & Associates sold out of Itron (ITRI) in Q4 2025, closing a stake of 7 shares — an estimated $872 sold.

Montag & Associates first reported a position in ITRI in Q3 2025 and held it in 1 quarter. The position peaked at $872 in Q3 2025. 437 funds tracked by Wall St. Rank hold ITRI as of Q4 2025.

Montag & Associates reported no remaining Itron position as of Q4 2025 after selling out during the quarter.
Montag & Associates sold 7 Itron shares in Q4 2025, an estimated $872.
Montag & Associates first reported a position in Itron in Q3 2025 and held it in 1 quarter.
Montag & Associates's Itron position peaked at $872 in Q3 2025.
437 funds tracked by Wall St. Rank held Itron as of Q4 2025.

Based on Montag & Associates's 13F filing for Q4 2025, filed 2 Feb 2026.